Reckitt Benckiser stock gets mixed broker targets before Q3 update
Published on 10/04/2026 at 21:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Reckitt Benckiser stock (ISIN GB00BSZBP530) was last at GBp 4,925 on October 2, 2026, after UBS and Jefferies published opposing target changes ahead of the company's Q3 trading update. The split reflects improving operating momentum alongside pressure in selected health categories.
Broker targets move apart
According to Yahoo Finance on October 1, 2026, UBS raised its price target to GBp 7,600 from GBp 7,400 and retained a Buy rating. The same report said Jefferies reduced its target to GBp 5,900 from GBp 6,100 while also retaining a Buy rating.
The broker gap is material against the October 2 price. The UBS target lies 54.3 percent above GBp 4,925, while Jefferies' target lies 19.8 percent above the same price, using the primary London listing and matching pence units.
Q2 growth provides the operating test
Reckitt's investor materials report Core Reckitt like-for-like net revenue growth of 2.7 percent in H1 2026 and 4.2 percent in Q2 2026. The acceleration was accompanied by a Core Reckitt gross profit margin of 60.9 percent and an adjusted operating profit margin of 24.8 percent, according to Reckitt.
The latest half-year figures give investors a clear split to monitor. Revenue growth improved by 1.5 percentage points from the H1 rate to the Q2 rate, while adjusted diluted EPS stood at 152.1p for H1 2026, down 9.7 percent on the prior-year period, according to Reckitt.
Consensus leaves room above the quote
MarketBeat reported on October 1, 2026, that Jefferies maintained a Buy rating after cutting its target to GBp 5,900. The portal listed a Moderate Buy consensus, an average target of GBp 6,178.86, a high target of GBp 6,500 and a low target of GBp 5,352, with four Buy ratings and three Hold ratings.
The average consensus target lies 25.5 percent above GBp 4,925. That comparison sits alongside a 52-week range of GBp 3,664 to GBp 6,522.92 and a market capitalization of GBP 31.3 billion as of October 2, 2026.
Q3 update is dated
Reckitt's investor calendar lists the Q3 2026 trading update for October 27, 2026, followed by a North America investor event on November 19, 2026, according to Reckitt. The upcoming release will test whether the 4.2 percent Q2 Core Reckitt growth rate can continue across the broader portfolio.
Reckitt stock stays below its yearly high
Reckitt Benckiser stock was last at GBp 4,925 on the London Stock Exchange on October 2, 2026 at 4:37 p.m. London time, up GBp 18 or 0.37 percent from the prior close. Trading volume was 845,019 shares, and the stock remained below its 52-week high of GBp 6,522.92.
Reckitt Benckiser stock at a glance
- Company: Reckitt Benckiser Group plc
- ISIN: GB00BSZBP530
- Ticker: RKT
- Trading venue: London Stock Exchange
- Price (as of October 2, 2026, 4:37 p.m. London time): GBp 4,925
- Market capitalization: GBP 31.3 billion (as of October 2, 2026)
- 52-week range: GBp 3,664-6,522.92 (as of October 2, 2026)
- Sector / Industry: Consumer Defensive / Household and Personal Products
Upcoming dates for Reckitt Benckiser stock
- October 27, 2026: Q3 2026 trading update
- November 19, 2026: Reckitt Focus On North America
